CBIO logo

Crescent Biopharma, Inc. (CBIO)

Profile

Full Name

Crescent Biopharma, Inc.

Ticker

NASDAQ: CBIO

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

January 10, 2014

Indexes

Not included

Website

https://crescentbiopharma.com

Employees

6

Key Details

Price

$14.40(+1.77%)

Market cap

$200.05M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(-100.00% YoY)

Annual EPS

-$59.00(-1.72% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $14.40
    CBIO price is $14.40

    30-Day Relative Volume

    0.52
    CBIO 30-day relative volume is 0.52

    Price Performance

    Price Most recent change

    +1.77%
    CBIO price was up +1.77% on Aug 29, 2025

    Price YTD change

    -42.4%
    CBIO price is down -42.4% since January 1st

    Price 1-year change

    -15.29%
    CBIO price is down -15.29% year-on-year

    Price 3-year change

    -82%
    CBIO price is down -82% over the past 3 years

    Price Range

    Price All-time high

    $2605.00
    CBIO price is currently -99.45% below its historical high of $2605.00

    Price 3-year low

    $10.83
    CBIO price is currently +32.96% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $200.05M
    CBIO market capitalization is $200.05 million

    Market cap 3-year change

    +377.04%
    CBIO market capitalization is up +377.04% over the past 3 years

    Market cap All-time high

    $871.03M
    CBIO market capitalization is currently -77.03% below its historical high of $871.03 million

    Market cap sector rank

    50.83%
    CBIO market capitalization is higher than 50.83% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +2054.56%
    CBIO shares outstanding is up +2054.56% year-on-year

    Shares Outstanding 3-Year Change

    +2550.25%
    CBIO shares outstanding is up +2550.25% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.29
    CBIO beta is 1.29

    200-day SMA

    $22.75
    CBIO price is currently -36.70% below its 200-day simple moving average

    50-day SMA

    $13.85
    CBIO price is currently +4.00% above its 50-day simple moving average

    RSI

    55.81
    CBIO 14-day relative strength index is 55.81

    Volume

    0.52
    CBIO 30-day relative volume is 0.52

    ATR

    $0.98
    CBIO average true range is $0.98

    10-day Historical Volatility

    39.57%
    CBIO 10-day historical volatility is 39.57%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    CBIO annual revenue is $0.00

    Revenue Analysts estimate

    -
    CBIO annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -100%
    CBIO annual revenue is down -100% year-on-year

    Revenue Sector rank

    28.67%
    CBIO annual revenue is higher than 28.67% of companies in Healthcare sector

    EPS

    EPS

    -$59.00
    CBIO annual earnings per share is -$59.00

    EPS Analysts estimate

    -$11.94
    CBIO annual earnings per share is currently +394.14% higher than the consensus analysts' forecast

    EPS 1-year change

    -1.72%
    CBIO annual earnings per share is down -1.72% year-on-year

    EPS Sector rank

    4.07%
    CBIO annual earnings per share is higher than 4.07% of companies in Healthcare sector

    Profit

    Gross profit

    -$35.20K
    CBIO annual gross profit is -$35.20 thousand

    Gross margin

    -
    CBIO annual gross profit margin value is unknown

    Operating profit

    -$32.51M
    CBIO annual operating income is -$32.51 million

    Operating margin

    -
    CBIO annual operating profit margin value is unknown

    Net income

    -$37.88M
    CBIO annual net profit is -$37.88 million

    Net margin

    -
    CBIO annual net profit margin value is unknown

    Expenses

    Total expenses

    $37.88M
    CBIO annual total expenses is $37.88 million

    Operating expenses

    $32.47M
    CBIO annual total operating expenses is $32.47 million

    Cost of goods sold

    $35.20K
    CBIO annual cost of goods sold is $35.20 thousand

    Selling, general & administrative expenses

    $0.00
    CBIO annual SGA is $0.00

    Depreciation and amortization

    $35.20K
    CBIO annual depreciation & amortization is $35.20 thousand

    Interest expense

    $0.00
    CBIO annual interest expense is $0.00

    Income tax

    $0.00
    CBIO annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$32.51M
    CBIO annual earnings before interest & taxes is -$32.51 million

    EBITDA

    -$32.47M
    CBIO annual EBITDA is -$32.47 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $11.09M
    CBIO annual total assets is $11.09 million

    Non current assets

    $813.00K
    CBIO annual long term assets is $813.00 thousand

    Current assets

    $11.09M
    CBIO annual total current assets is $11.09 million

    Cash and cash equivalents

    $10.72M
    CBIO annual cash & cash equivalents is $10.72 million

    Accounts receivable

    -
    CBIO annual accounts receivable value is unknown

    Inventory

    $0.00
    CBIO annual inventory is $0.00

    Liabilities

    Total liabilities

    $5.78M
    CBIO annual total liabilities is $5.78 million

    Long term liabilities

    $41.48M
    CBIO annual total long term liabilities is $41.48 million

    Current liabilities

    $5.78M
    CBIO annual total current liabilities is $5.78 million

    Accounts payable

    $329.30K
    CBIO annual accounts payable is $329.30 thousand

    Debt

    Total debt

    $66.80K
    CBIO annual total debt is $66.80 thousand

    Total debt 1-year change

    -91.74%
    CBIO annual total debt is down -91.74% year-on-year

    Long term debt

    $0.00
    CBIO annual long term debt is $0.00

    Short term debt

    $66.80K
    CBIO annual short term debt is $66.80 thousand

    Equity & Capital

    Shareholders equity

    $5.31M
    CBIO annual stockholders equity is $5.31 million

    Book value

    $5.31M
    CBIO annual book value is $5.31 million

    Retained earnings

    -$494.36M
    CBIO annual retained earnings is -$494.36 million

    Working capital

    $5.31M
    CBIO annual working capital is $5.31 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$31.10M
    CBIO annual cash flow from operations is -$31.10 million

    Cash from operations 1-year change

    +10.84%
    CBIO annual cash flow from operations is up +10.84% year-on-year

    Cash from investing

    $20.00K
    CBIO annual cash flow from investing activities is $20.00 thousand

    Cash from investing 1-year change

    +193.46%
    CBIO annual cash flow from investing activities is up +193.46% year-on-year

    Cash from financing

    $5400.00
    CBIO annual cash flow from financing activities is $5400.00

    Cash from financing 1-year change

    -99.98%
    CBIO annual cash flow from financing activities is down -99.98% year-on-year

    CAPEX

    CAPEX

    $10.00K
    CBIO annual capital expenditures is $10.00 thousand

    CAPEX 1-year change

    -53.27%
    CBIO annual capital expenditures is down -53.27% year-on-year

    Free Cash Flow

    Free cash flow

    -$31.11M
    CBIO annual free cash flow is -$31.11 million

    Free cash flow 1-year change

    +10.87%
    CBIO annual free cash flow is up +10.87% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    CBIO annual gross profit margin value is unknown

    Operating margin

    -
    CBIO annual operating profit margin value is unknown

    Net margin

    -
    CBIO annual net profit margin value is unknown

    ROA & ROE

    ROA

    -134.30%
    CBIO annual return on assets is -134.30%

    ROE

    -173.25%
    CBIO annual return on equity is -173.25%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    CBIO price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    CBIO price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.48
    CBIO price to book ratio is 1.48

    PB ratio Sector rank

    44.97%
    CBIO price to book ratio is higher than 44.97% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    CBIO price to sales ratio value is unknown

    PS ratio Sector rank

    -
    CBIO price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $49.05M
    CBIO enterprise value is $49.05 million

    Enterprise value Sector rank

    40.03%
    CBIO enterprise value is higher than 40.03% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -1.42
    CBIO EV/EBITDA is -1.42

    EV/EBITDA Sector rank

    41.56%
    CBIO EV/EBITDA is higher than 41.56% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.92
    CBIO annual current ratio is 1.92

    Quick ratio

    1.92
    CBIO annual quick ratio is 1.92

    Leverage

    Debt to equity

    0.01
    CBIO annual debt to equity ratio is 0.01

    Interest coverage ratio

    -
    CBIO annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    CBIO piotroski f-score value is unknown

    Altman Z-Score

    -50.72
    CBIO altman z-score is -50.72

    Analyst ratings

    Recent major analysts updates

    Aug 27, 25 HC Wainwright & Co.
    Buy
    Aug 25, 25 Jefferies
    Buy
    Aug 11, 25 HC Wainwright & Co.
    Buy
    Jul 14, 25 Wedbush
    Outperform
    Jun 25, 25 Stifel
    Buy
    Jun 18, 25 LifeSci Capital
    Outperform
    Nov 15, 21 Raymond James
    Market Perform
    Aug 6, 21 Raymond James
    Outperform
    Apr 29, 21 Raymond James
    Outperform
    Feb 10, 21 Piper Sandler
    Overweight

    Institutional Ownership

    Screeners with CBIO included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Crescent Biopharma, Inc.?
    • Does Crescent Biopharma, Inc. pay dividends?
    • What sector is Crescent Biopharma, Inc. in?
    • What industry is Crescent Biopharma, Inc. in?
    • What country is Crescent Biopharma, Inc. based in?
    • When did Crescent Biopharma, Inc. go public?
    • Is Crescent Biopharma, Inc. in the S&P 500?
    • Is Crescent Biopharma, Inc. in the NASDAQ 100?
    • Is Crescent Biopharma, Inc. in the Dow Jones?
    • When was Crescent Biopharma, Inc.'s last earnings report?
    • When does Crescent Biopharma, Inc. report earnings?

    What is the ticker symbol for Crescent Biopharma, Inc.?

    The ticker symbol for Crescent Biopharma, Inc. is NASDAQ:CBIO

    Does Crescent Biopharma, Inc. pay dividends?

    No, Crescent Biopharma, Inc. does not pay dividends

    What sector is Crescent Biopharma, Inc. in?

    Crescent Biopharma, Inc. is in the Healthcare sector

    What industry is Crescent Biopharma, Inc. in?

    Crescent Biopharma, Inc. is in the Biotechnology industry

    What country is Crescent Biopharma, Inc. based in?

    Crescent Biopharma, Inc. is headquartered in United States

    When did Crescent Biopharma, Inc. go public?

    Crescent Biopharma, Inc.'s initial public offering (IPO) was on January 10, 2014

    Is Crescent Biopharma, Inc. in the S&P 500?

    No, Crescent Biopharma, Inc. is not included in the S&P 500 index

    Is Crescent Biopharma, Inc. in the NASDAQ 100?

    No, Crescent Biopharma, Inc. is not included in the NASDAQ 100 index

    Is Crescent Biopharma, Inc. in the Dow Jones?

    No, Crescent Biopharma, Inc. is not included in the Dow Jones index

    When was Crescent Biopharma, Inc.'s last earnings report?

    Crescent Biopharma, Inc.'s most recent earnings report was on August 2, 2018

    When does Crescent Biopharma, Inc. report earnings?

    The date for Crescent Biopharma, Inc.'s next earnings report has not been announced yet
    On this page